NAD nasal spray is a product that delivers nicotinamide adenine dinucleotide, a molecule your cells use to produce energy and repair DNA, directly through the nose. It’s marketed as a way to boost NAD+ levels in the brain more efficiently than oral supplements or even IV infusions, taking advantage of nerve pathways that connect the nasal cavity to the central nervous system. Most NAD nasal sprays are made by compounding pharmacies and are not FDA-approved drugs, placing them in a gray area between supplement and pharmaceutical.
How NAD+ Works in the Body
NAD+ is a coenzyme found in every living cell. It plays a central role in converting food into usable energy, activating proteins that repair damaged DNA, and regulating your body’s internal clock. NAD+ levels decline naturally with age, dropping significantly by middle age. This decline is linked to many hallmarks of aging, including reduced cellular energy, increased inflammation, and impaired brain function.
The challenge with restoring NAD+ is getting it where it needs to go. Taken orally, NAD+ breaks down in the digestive system before much of it reaches the bloodstream. Even when it does enter the blood, a protective barrier between the bloodstream and the brain (called the blood-brain barrier) blocks most large molecules from crossing into brain tissue. This is the core problem that nasal delivery attempts to solve.
Why Deliver It Through the Nose
The nasal cavity has a unique anatomical advantage: two sets of nerves, the olfactory and trigeminal nerves, create direct pathways from the nose into the brain. A technique first developed and patented by researcher William H. Frey in 1989 exploits these pathways to bypass the blood-brain barrier entirely. When a substance is sprayed into the nose, it can travel along these nerve routes and reach both the front and back regions of the brain within 30 to 60 minutes.
The nasal lining is also highly vascularized, meaning it has a dense network of blood vessels that absorb molecules quickly. This combination of nerve-based transport and rich blood supply gives intranasal delivery higher bioavailability for brain-targeted compounds than oral or even intravenous routes. Animal studies have confirmed that intranasal NAD+ delivery significantly increases NAD+ concentrations in brain tissue.
What the Research Shows
Most of the published research on intranasal NAD+ comes from animal models, not human clinical trials. The most notable study, published in the journal Rejuvenation Research, tested intranasal NAD+ in rats with stroke-like brain injuries. Rats that received intranasal NAD+ showed profoundly reduced brain damage when assessed at both 24 and 72 hours after the injury. The treatment also significantly reduced neurological deficits, meaning the animals recovered more brain function. Interestingly, nicotinamide (a related B vitamin often sold as a supplement) delivered the same way did not produce the same protective effect, suggesting the intact NAD+ molecule itself was responsible.
These findings point to NAD+ metabolism as a potential target for brain injuries and neurological diseases where cells are under stress. Researchers have noted possible relevance to conditions involving DNA repair enzyme overactivation, which rapidly depletes cellular NAD+ and contributes to cell death. However, no large-scale human trials have confirmed these benefits for everyday use, cognitive enhancement, or anti-aging purposes. The gap between promising animal data and proven human outcomes remains significant.
Typical Dosing and How to Use It
NAD nasal sprays from compounding pharmacies typically contain 300 mg per milliliter, with each spray delivering about 30 mg of NAD+. A standard daily dose is one to two sprays per nostril (two to four sprays total), taken in the morning or evening. Some protocols recommend higher dosing of two to three sprays per nostril twice daily, though this varies by provider.
Storage matters. NAD+ is not a stable molecule at room temperature. Most compounding pharmacies instruct you to keep the spray refrigerated between 36 and 46°F and to use it within 28 days of opening. Leaving it unrefrigerated or using it past this window may reduce its potency.
Side Effects and Safety Concerns
NAD+ precursors taken orally tend to produce mild side effects: nausea, bloating, and occasional skin flushing or itching. Nasal delivery can add localized irritation, a burning sensation, or a runny nose, particularly in the first few uses. These effects are generally temporary.
The more serious safety concern involves product quality. The FDA has specifically flagged that some compounders use food-grade NAD+ to make sterile products. Food-grade ingredients carry a higher risk of contamination with bacteria and endotoxins, substances that can trigger severe immune reactions. The FDA has received adverse event reports following use of NAD+ injectable drugs (made from similarly sourced ingredients) including severe chills, shaking, vomiting, and fatigue serious enough to require medical treatment. While these reports involved IV products rather than nasal sprays, the underlying ingredient quality issue applies to any compounded NAD+ product.
People taking blood pressure medications should be cautious, as NAD+ and its precursors may lower blood pressure. Combining them with antihypertensive drugs could cause blood pressure to drop too low.
Regulatory Status
NAD nasal sprays are not FDA-approved for any medical condition. They are produced by compounding pharmacies, which operate under a different regulatory framework than pharmaceutical manufacturers. Compounding pharmacies can legally prepare customized medications, but their products do not go through the rigorous testing for safety, efficacy, and manufacturing consistency that FDA-approved drugs require.
This means the NAD+ concentration, purity, and sterility of a nasal spray can vary from one pharmacy to another. There is no standardized formulation, no required clinical testing before sale, and no guarantee that what’s on the label matches what’s in the bottle. If you’re considering a NAD nasal spray, the source matters as much as the molecule itself. Pharmacies that follow USP compounding standards and use pharmaceutical-grade ingredients (not food-grade) offer a meaningfully lower risk profile than those that don’t.
NAD Nasal Spray vs. Other Forms
NAD+ can also be taken as oral supplements (usually as precursors like nicotinamide riboside or NMN), through IV infusions, or via subcutaneous injection. Each route has trade-offs.
- Oral precursors are the most convenient and widely available. They don’t deliver NAD+ directly but provide building blocks your body converts into NAD+. Absorption is modest, and very little crosses into the brain.
- IV infusions deliver NAD+ directly into the bloodstream at high concentrations but still face the blood-brain barrier. Sessions typically last one to four hours, cost several hundred dollars each, and require a clinical setting.
- Nasal spray offers the theoretical advantage of bypassing the blood-brain barrier through direct nerve pathways, with at-home convenience. The trade-off is less clinical evidence and variable product quality.
For people primarily interested in general cellular health and energy, oral precursors have the most human research behind them, with studies using doses up to 300 mg daily showing a reasonable safety profile. For people specifically targeting brain-related benefits, the intranasal route has a stronger biological rationale, but the evidence base is still largely preclinical. No head-to-head human trials have compared these delivery methods for cognitive or neurological outcomes.